Clinical Trial Update: Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating povidone iodine nasal application to prevent intraoperative spread of SARS-CoV-2 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Acute Respiratory Disease

Drugs mentioned

• povidone iodine nasal application (povidone-iodine)

Snippet

Sponsor: University of Iowa | Conditions: SARS-CoV-2 Acute Respiratory Disease | Phase 4 | Status: WITHDRAWN